Driving CAR T-Cell Therapy From Bench to Bedside – Biotechin.Asia
|
Driving CAR T-Cell Therapy From Bench to Bedside
Biotechin.Asia Scientists first began to experiment with CAR T cells in the late 1980s, when a trio of researchers genetically engineered T cells to express a chimeric T cell receptor fused with a variable domain of an antibody to redirect their specificity (Gross et … |
